Diplomat Pharmacy Inc logo

DPLO - Diplomat Pharmacy Inc Share Price

$4 0.0  0.0%

Last Trade - 07/02/20

Sector
Consumer Defensives
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £3.82bn
Position in Universe th / 6566
Bullish
Bearish
Unlock DPLO Revenue
Momentum
Relative Strength (%)
1m -4.57%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2013 2014 2015 2016 2017 2018 2019E 2020E CAGR / Avg
1,515 2,215 3,367 4,410 4,485 5,493 4,966 4,440 +29.4%
+265.9 +14.2 -67.8
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the nine months ended 30 September 2019,Diplomat Pharmacy Inc revenues decreased 7% to $3.85B. Netloss increased from $4.2M to $351M. Revenues reflect adecrease in demand for the Company's products and servicesdue to unfavorable market conditions. Higher net lossreflects Selling, General & Administrative Expens increasefrom $81.7M to $238.7M (expense), Interest Expense increaseof 3% to $32M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

DPLO Revenue Unlock DPLO Revenue

Net Income

DPLO Net Income Unlock DPLO Revenue

Normalised EPS

DPLO Normalised EPS Unlock DPLO Revenue

PE Ratio Range

DPLO PE Ratio Range Unlock DPLO Revenue

Dividend Yield Range

DPLO Dividend Yield Range Unlock DPLO Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
DPLO EPS Forecasts Unlock DPLO Revenue
Profile Summary

Diplomat Pharmacy, Inc. (Diplomat) operates a specialty pharmacy business, which stocks, dispenses and distributes prescriptions for various biotechnology and specialty pharmaceutical manufacturers. The Company operates through specialty pharmacy services segment. The Company's primary focus is on medication management programs for individuals with chronic diseases, including oncology, immunology, hepatitis, multiple sclerosis, specialty infusion therapy, and various other serious and/or long-term conditions. The Company provides specialty pharmacy support services to a national network of retailers and independent pharmacy groups, hospitals and health systems. The Company offers various services, such as specialty drug dispensing, retail specialty services, hospital and health system services, and hub services. The Company's patient care system is used to coordinate and track patient adherence and safety.

Directors
Last Annual December 31st, 2018
Last Interim September 30th, 2019
Incorporated March 26, 1975
Public Since October 10, 2014
No. of Shareholders: 39
No. of Employees: 2,335
Sector Consumer Defensives
Industry Food & Drug Retailing
Index
Exchange New York Stock Exchange
Shares in Issue 75,973,963
Free Float (0.0%)
Eligible for
ISAs
SIPPs
DPLO Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for DPLO
Upcoming Events for DPLO
Frequently Asked Questions for Diplomat Pharmacy Inc
What is the Diplomat Pharmacy Inc share price?

As of 07/02/20, shares in Diplomat Pharmacy Inc are trading at $4, giving the company a market capitalisation of £n/a. This share price information is delayed by 15 minutes.

How has the Diplomat Pharmacy Inc share price performed this year?

Shares in Diplomat Pharmacy Inc are currently trading at $4 and the price has moved by -70.65% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Diplomat Pharmacy Inc price has moved by -74.14% over the past year.

What are the analyst and broker recommendations for Diplomat Pharmacy Inc?

Of the analysts with advisory recommendations for Diplomat Pharmacy Inc, there are there are currently 0 "buy" , 4 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Diplomat Pharmacy Inc is Sell. You can view the full broker recommendation list by unlocking its StockReport.

When will Diplomat Pharmacy Inc next release its financial results?

Diplomat Pharmacy Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2020-09-30
What is the Diplomat Pharmacy Inc dividend yield?

Diplomat Pharmacy Inc does not currently pay a dividend.

Does Diplomat Pharmacy Inc pay a dividend?

Diplomat Pharmacy Inc does not currently pay a dividend.

When does Diplomat Pharmacy Inc next pay dividends?

Diplomat Pharmacy Inc does not currently pay a dividend.

How do I buy Diplomat Pharmacy Inc shares?

To buy shares in Diplomat Pharmacy Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Diplomat Pharmacy Inc?

Shares in Diplomat Pharmacy Inc are currently trading at $4, giving the company a market capitalisation of £n/a.

Where are Diplomat Pharmacy Inc shares listed? Where are Diplomat Pharmacy Inc shares listed?

Here are the trading details for Diplomat Pharmacy Inc:

Country of listing: United States
Exchange: NYQ
Ticker Symbol: DPLO
What kind of share is Diplomat Pharmacy Inc?

We were not able to load our ranking data for Diplomat Pharmacy Inc

Is there a Diplomat Pharmacy Inc share price forecast 2021?

We were not able to load any forecast data for Diplomat Pharmacy Inc.

How can I tell whether the Diplomat Pharmacy Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Diplomat Pharmacy Inc. Over the past six months, the relative strength of its shares against the market has been -40.33%. At the current price of $4, shares in Diplomat Pharmacy Inc are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Diplomat Pharmacy Inc PE Ratio?

We were not able to find PE ratio data for Diplomat Pharmacy Inc.

Who are the key directors of Diplomat Pharmacy Inc?

We were unable to find the directors for Diplomat Pharmacy Inc.

Who are the major shareholders of Diplomat Pharmacy Inc?

Here are the top five shareholders of Diplomat Pharmacy Inc based on the size of their shareholding:

Hagerman (Philip R) Individual Investor
Percentage owned: 22.81% (17.3m shares)
BlackRock Institutional Trust Company, N.A. Investment Advisor
Percentage owned: 11.36% (8.63m shares)
Stephens Capital Management Investment Advisor
Percentage owned: 8.57% (6.51m shares)
The Vanguard Group, Inc. Investment Advisor/Hedge Fund
Percentage owned: 7.66% (5.82m shares)
Armistice Capital LLC Hedge Fund
Percentage owned: 7.11% (5.40m shares)
Similar to DPLO
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.